Press Releases

GlobeNewswire, Inc.

More than two months of multidisciplinary execution deliver the material and data required to move Skaergaard from resource definition toward mine planning, metallurgical flowsheet development, and an Initial Assessment 4,480 meters of diamond...

GlobeNewswire, Inc.

Besi joins Applied's EPIC Center as an Innovation Partner, extending a collaboration that began in 2020 with the companies' joint Hybrid Bonding Center of Excellence in Singapore Expanded collaboration targets next-generation 3D IC scaling, logic...

GlobeNewswire, Inc.

TORONTO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- As Canada’s inflammatory bowel disease (IBD) population continues to grow, Crohn’s and Colitis Canada is committed to invest 1.5 million over three years across four research projects aimed at advancing...

GlobeNewswire, Inc.

New 50 mg tablet formulation delivers an improved pharmacokinetic profile and enables greater exposure and patient convenience FDA removal of the prior drug exposure limit provides greater dosing flexibility in future clinical trials CervoMed...

Maryland Department of the Environment

Settlement of complaint for air pollution violations includes $600,000 penalty, requirement for medical waste incineration to cease BALTIMORE (Oct. 1, 2026) – Incinerator operations at the Curtis Bay Energy facility in South Baltimore will come to...

GlobeNewswire, Inc.

WALTHAM, Mass., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced the...

GlobeNewswire, Inc.

Substantially all planned REO 033 clinical sites are now activated, with multiple patients currently on study Company expects to have sufficient Part A data to provide an interim clinical update by year-end 2026 FDA alignment provides potential...

GlobeNewswire, Inc.

SAN DIEGO and SEATTLE and SINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Callio Therapeutics (“Callio” or “the Company”), a global, clinical-stage biotechnology company advancing dual-payload antibody-drug conjugates (ADCs) as the next frontier of...

GlobeNewswire, Inc.

Oral presentation will highlight previously reported data demonstrating early stabilization or improvement in mFARS scores among LX2006-treated participants compared with propensity-matched control cohort from UNIFAI natural history study...

GlobeNewswire, Inc.

Collaboration extends existing relationship with the Tier 1 pharmaceutical customer into cell therapy programs End-to-end supply chain combines 4basebio's proprietary opDNA® enzymatic DNA starting material with TriLink's industry-leading GMP mRNA...

GlobeNewswire, Inc.

PETACH TIKVA, Israel, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where...

GlobeNewswire, Inc.

FRAMINGHAM, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a provider of healthcare data and analytics, today announced that it has joined the Network Advertising Initiative (NAI). Membership in the NAI underscores...

GlobeNewswire, Inc.

WILMINGTON, N.C., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Augwork AI, a Wilmington-based artificial intelligence company, today announced its launch with a practical platform for businesses seeking to move beyond AI experimentation and apply artificial...

GlobeNewswire, Inc.

Owned land with a pathway to grid and behind-the-meter natural gas power expands FingerMotion's Alberta AI infrastructure footprint WEST PALM BEACH, Fla., Oct. 01, 2026 (GLOBE NEWSWIRE) -- FingerMotion, Inc. (Nasdaq: FNGR) ("FingerMotion" or the...

GlobeNewswire, Inc.

PASADENA, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Doheny Eye Institute, one of the nation’s leading vision research institutions, announced that its affiliated experts from UCLA Stein Eye Institute will share research findings and clinical...

GlobeNewswire, Inc.

New U.S. patent expands intellectual property foundation for DARE-HPV, a potential first-in-category treatment targeting persistent high-risk HPV infection DARE-HPV Phase 2 study underway with topline results expected in 2027; program supported by...

GlobeNewswire, Inc.

Eton Pharmaceuticals now holds exclusive commercialization rights for IMPAVIDO in the United States Eton has integrated full Eton Cares® patient support, including $0 co-pay for eligible commercially insured patients and expanded patient...

GlobeNewswire, Inc.

FREMONT, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Interlink Electronics, Inc. (Nasdaq: LINK), a leading provider of sensor and printed electronics solutions, will participate in a webcast presentation and host one-on-one meetings with investors...

GlobeNewswire, Inc.

MONTREAL, Oct. 01, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to...

GlobeNewswire, Inc.

Southfield, MI, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Michigan Contact Lens, a specialty contact lens practice led by Dr. Shira Kresch, OD, MS, FAAO, has completed its first year at an expanded facility at 17000 West 10 Mile Road in Southfield,...